By Scott Hensley Consider the cost of a new option for treating advanced prostate cancer, before you get carried away with enthusiasm. Provenge, an immune-system booster just approved by the Food and Drug Administration, will cost $93,000. What do patients
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/04/by_scott_hensley_consider_the.html?ft=1&f=103537970
Posted
Apr 30 2010, 09:55 AM
by
NPR Blogs: Shots - Health News